Evaluate if Response to Infliximab or Adalimumab May be Regained With an Immunomodulator
Clinical trial NCT02413047 · TERMINATED
Trial details
- NCT number
- NCT02413047
- Sponsor
- Indiana University
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2018-02-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.